SC rejects Novartis plea on cancer drug patent

Updated: April 01, 2013 13:04 IST

The Supreme Court on Monday rejected a plea by Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India. The patents would be granted only for genuine inventions, cited the Supreme Court, a decision that paves way for Indian companies to manufacture generic drugs for cancer.

top videos

most viewed

other videos